News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Martins Ryan
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Paid exercise price by delivering 346 shares
@ $15.64, valued at
$5.4k
Paid exercise price by delivering 753 shares
@ $15.46, valued at
$11.6k
|
|
07/05/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 5,834 shares
@ $0 Paid exercise price by delivering 2,018 shares
@ $18.95, valued at
$38.2k
|
|
04/06/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Sold 8,721 shares
@ $14.95, valued at
$130.4k
|
|
04/04/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 5,833 shares
@ $0 Paid exercise price by delivering 2,018 shares
@ $15.23, valued at
$30.7k
Granted 7,500 shares
@ $0 Paid exercise price by delivering 2,594 shares
@ $15.23, valued at
$39.5k
|
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Paid exercise price by delivering 1,750 shares
@ $13.97, valued at
$24.4k
Sold 2,540 shares
@ $13.89, valued at
$35.3k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Sold 3,000 shares
@ $13.11, valued at
$39.3k
Sold 592 shares
@ $12.7, valued at
$7.5k
Paid exercise price by delivering 592 shares
@ $13.24, valued at
$7.8k
Exercised 3,000 options to buy
@ $3.11, valued at
$9.3k
|
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2023 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Sold 5,947 shares
@ $12.51, valued at
$74.4k
|
|
09/30/2022 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 5,833 shares
@ $0 Paid exercise price by delivering 2,018 shares
@ $5.76, valued at
$11.6k
|
|
09/13/2022 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 15,000 shares
@ $0 |
|
04/13/2022 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Paid exercise price by delivering 1,022 shares
@ $5.23, valued at
$5.3k
|
|
02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/09/2021 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 7,500 shares
@ $0 Granted 57,500 options to buy
@ $23.01, valued at
$1.3M
|
|
02/19/2020 |
4
| Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns:
| Granted 47,500 options to buy
@ $32.5, valued at
$1.5M
|
|
11/08/2019 |
3
| Martins Ryan (CFO) has filed a Form 3 on 89bio, Inc. |
|
|